Showing results (1711-1720 of 1,912) with videos related to

Sort By:
Pageof 192
Hepatology (Baltimore, Md.)|September 10, 2024
Association of HDV infection and HCC, hepatic decompensation, and all-cause and liver-related death in a national cohortBinu V John, Dustin Bastaich, Mahmoud Manouchehri Amoli, et al.
The Science of the Total Environment|November 15, 2024
Remote sensing and spatial analysis reveal unprecedented cyanobacteria bloom dynamics associated with elephant mass mortalityDavide Lomeo, Emma J Tebbs, Nlingisisi D Babayani, et al.
The American Journal of Gastroenterology|June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis CChihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.
Medical Care|March 19, 2020
Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative MethodsVera Yakovchenko, Edward J Miech, Matthew J Chinman, et al.
Gene Therapy|March 8, 2008
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trialC L White, K R Twigger, L Vidal, et al.
Hepatology Communications|July 5, 2024
Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction-associated steatotic liver diseaseDavid E Kaplan, Craig C Teerlink, Tae-Hwi Schwantes-An, et al.
The American Journal of Pathology|June 19, 2026
Unbiased Spatial Proteomics Uncovers Hepatic In Situ Regulation in Alcohol-Associated HepatitisLe Z Day, Maria Hernandez-Tejero, Nidhi Jalan Sakrikar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
Gastroenterology|October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok, Richard K Sterling, James E Everhart, et al.
Breast Cancer Research and Treatment|November 2, 2011
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancerG Somlo, C L Martel, S K Lau, et al.
Pageof 192